K-115 phase 3 add-on study with timolol
Phase 3
- Conditions
- POAG or OH
- Registration Number
- JPRN-jRCT2080221659
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. POAG or OH patients
2. IOP after timolol run-in period >= 18mmHg
Exclusion Criteria
1.Patients whose visual acuity is below 0.3
2.Patients thought to use glaucoma medication during this trial
3.Patients thought to wear contact lenses during this trial
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method